An apparent pseudo-exon acts both as an alternative exon that leads to nonsense-mediated decay and as a zero-length exon

被引:32
作者
Grellscheid, SN [1 ]
Smith, CWJ [1 ]
机构
[1] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England
基金
英国惠康基金;
关键词
D O I
10.1128/MCB.26.6.2237-2246.2006
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Pseudo-exons are intronic sequences that are flanked by apparent consensus splice sites but that are not observed in spliced mRNAs. Pseudo-exons are often difficult to activate by mutation and have typically been viewed as a conceptual challenge to our understanding of how the spliceosome discriminates between authentic and cryptic splice sites. We have analyzed an apparent pseudo-exon located downstream of mutually exclusive exons and 3 of the rat alpha-tropomyosin (TM) gene. The TM pseudo-exon is conserved among mammals and has a conserved profile of predicted splicing enhancers and silencers that is more typical of a genuine exon than a pseudo-exon. Splicing of the pseudo-exon is fully activated for splicing to exon 3 by a number of simple mutations. Splicing of the pseudo-exon to exon 3 is predicted to lead to nonsense-mediated decay (NMD). In contrast, when "prespliced" to exon 2 it follows a "zero length exon" splicing pathway in which a newly generated 5' splice site at the junction with exon 2 is spliced to exon 4. We propose that a subset of apparent pseudo-exons, as exemplified here, are actually authentic alternative exons whose inclusion leads to NMD.
引用
收藏
页码:2237 / 2246
页数:10
相关论文
共 44 条
  • [1] Mechanisms of alternative pre-messenger RNA splicing
    Black, DL
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 2003, 72 : 291 - 336
  • [2] Cytomegalovirus, C-reactive protein and atherosclerosis. Infectious agents and inflammation as possible causative factor of acute coronary syndromes
    Burazor, I
    Burazor, M
    Tasic, G
    Burazor, N
    Burazor, Z
    Karanovic, N
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2004, 5 (01) : 3 - 3
  • [3] Subdivision of large introns in Drosophila by recursive splicing at nonexonic elements
    Burnette, JM
    Miyamoto-Sato, E
    Schaub, MA
    Conklin, J
    Lopez, AJ
    [J]. GENETICS, 2005, 170 (02) : 661 - 674
  • [4] Alternative splicing:: multiple control mechanisms and involvement in human disease
    Cáceres, JF
    Kornblihtt, AR
    [J]. TRENDS IN GENETICS, 2002, 18 (04) : 186 - 193
  • [5] ESEfinder: a web resource to identify exonic splicing enhancers
    Cartegni, L
    Wang, JH
    Zhu, ZW
    Zhang, MQ
    Krainer, AR
    [J]. NUCLEIC ACIDS RESEARCH, 2003, 31 (13) : 3568 - 3571
  • [6] Binding of hnRNP H to an exonic splicing silencer is involved in the regulation of alternative splicing of the rat β-tropomyosin gene
    Chen, CD
    Kobayashi, R
    Helfman, DM
    [J]. GENES & DEVELOPMENT, 1999, 13 (05) : 593 - 606
  • [7] Functional significance of deep intronic mutation in the ATM gene and evidence for an alternative Exon 28a
    Coutinho, G
    Xie, JY
    Du, LT
    Brusco, A
    Krainer, AR
    Gatti, RA
    [J]. HUMAN MUTATION, 2005, 25 (02) : 118 - 124
  • [8] Enhancer elements activate the weak 3′ splice site of α-tropomyosin exon 2
    Dye, DT
    Buvoli, M
    Mayer, SA
    Lin, CH
    Patton, JG
    [J]. RNA, 1998, 4 (12) : 1523 - 1536
  • [9] Regulated tissue-specific alternative splicing of enhanced green fluorescent protein transgenes conferred by α-tropomyosin regulatory elements in transgenic mice
    Ellis, PD
    Smith, CWJ
    Kemp, P
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (35) : 36660 - 36669
  • [10] Nonclassical splicing mutations in the coding and noncoding regions of the ATM gene:: Maximum entropy estimates of splice junction strengths
    Eng, L
    Coutinho, G
    Nahas, S
    Yeo, G
    Tanouye, R
    Babaei, M
    Dörk, T
    Burge, C
    Gatti, RA
    [J]. HUMAN MUTATION, 2004, 23 (01) : 67 - 76